Abstract
The administration of oral raloxifene in 30 postmenopausal hypertensive women was evaluated to demonstrate its effect on arterial stiffness. Casual and ambulatory blood pressure (BP) and pulse-wave velocity (PWV) data were obtained before and after patients received raloxifene, estrogen-progestin replacement therapy, or placebo in a randomized crossover study. It was shown that the 2 therapies decreased BP and carotid-femoral PWV, and the effect of raloxifene on vascular compliance was independent of the effects on BP.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Administration, Oral
-
Aged
-
Blood Pressure / drug effects*
-
Blood Pressure Monitoring, Ambulatory
-
Cross-Over Studies
-
Estrogen Replacement Therapy*
-
Female
-
Humans
-
Hypertension / drug therapy*
-
Postmenopause
-
Raloxifene Hydrochloride / pharmacology*
-
Raloxifene Hydrochloride / therapeutic use*
-
Selective Estrogen Receptor Modulators / pharmacology*
-
Selective Estrogen Receptor Modulators / therapeutic use*
-
Vascular Resistance
Substances
-
Selective Estrogen Receptor Modulators
-
Raloxifene Hydrochloride